H3B-8800, an orally available small-molecule splicing modulator, induces lethality in spliceosome-mutant cancers
Seiler, Michael, Yoshimi, Akihide, Darman, Rachel, Chan, Betty, Keaney, Gregg, Thomas, Michael, Agrawal, Anant A, Caleb, Benjamin, Csibi, Alfredo, Sean, Eckley, Fekkes, Peter, Karr, Craig, Klimek, Virginia, Lai, George, Lee, Linda, Kumar, Pavan, Lee, Stanley Chun-Wei, Liu, Xiang, Mackenzie, Crystal, Meeske, Carol, Mizui, Yoshiharu, Padron, Eric, Park, Eunice, Pazolli, Ermira, Peng, Shouyong, Prajapati, Sudeep, Taylor, Justin, Teng, Teng, Wang, John, Warmuth, Markus, Yao, Huilan, Yu, Lihua, Zhu, Ping, Abdel-Wahab, Omar, Smith, Peter G, Buonamici, Silvia
Published in Nature medicine (01.04.2018)
Published in Nature medicine (01.04.2018)
Get full text
Journal Article
Sensitivity to splicing modulation of BCL2 family genes defines cancer therapeutic strategies for splicing modulators
Aird, Daniel, Teng, Teng, Huang, Chia-Ling, Pazolli, Ermira, Banka, Deepti, Cheung-Ong, Kahlin, Eifert, Cheryl, Furman, Craig, Wu, Zhenhua Jeremy, Seiler, Michael, Buonamici, Silvia, Fekkes, Peter, Karr, Craig, Palacino, James, Park, Eunice, Smith, Peter G., Yu, Lihua, Mizui, Yoshiharu, Warmuth, Markus, Chicas, Agustin, Corson, Laura, Zhu, Ping
Published in Nature communications (11.01.2019)
Published in Nature communications (11.01.2019)
Get full text
Journal Article
p38MAPK plays a crucial role in stromal-mediated tumorigenesis
Alspach, Elise, Flanagan, Kevin C, Luo, Xianmin, Ruhland, Megan K, Huang, Hui, Pazolli, Ermira, Donlin, Maureen J, Marsh, Timothy, Piwnica-Worms, David, Monahan, Joseph, Novack, Deborah V, McAllister, Sandra S, Stewart, Sheila A
Published in Cancer discovery (01.06.2014)
Published in Cancer discovery (01.06.2014)
Get full text
Journal Article
Senescent Stromal-Derived Osteopontin Promotes Preneoplastic Cell Growth
PAZOLLI, Ermira, XIANMIN LUO, STEWART, Sheila A, BREHM, Sarah, CARBERY, Kelly, CHUNG, Jun-Jae, PRIOR, Julie L, DOHERTY, Jason, DEMEHRI, Shadmehr, SALAVAGGIONE, Lorena, PIWNICA-WORMS, David
Published in Cancer research (Chicago, Ill.) (01.02.2009)
Published in Cancer research (Chicago, Ill.) (01.02.2009)
Get full text
Journal Article
Osteopontin stimulates preneoplastic cellular proliferation through activation of the MAPK pathway
Luo, Xianmin, Ruhland, Megan K, Pazolli, Ermira, Lind, Anne C, Stewart, Sheila A
Published in Molecular cancer research (01.08.2011)
Published in Molecular cancer research (01.08.2011)
Get full text
Journal Article
Chromatin Remodeling Underlies the Senescence-Associated Secretory Phenotype of Tumor Stromal Fibroblasts That Supports Cancer Progression
PAZOLLI, Ermira, ALSPACH, Elise, MILCZAREK, Agnieszka, PRIOR, Julie, PIWNICA-WORMS, David, STEWART, Sheila A
Published in Cancer research (Chicago, Ill.) (01.05.2012)
Published in Cancer research (Chicago, Ill.) (01.05.2012)
Get full text
Journal Article
AZD9496: An Oral Estrogen Receptor Inhibitor That Blocks the Growth of ER-Positive and ESR1-Mutant Breast Tumors in Preclinical Models
Weir, Hazel M, Bradbury, Robert H, Lawson, Mandy, Rabow, Alfred A, Buttar, David, Callis, Rowena J, Curwen, Jon O, de Almeida, Camila, Ballard, Peter, Hulse, Michael, Donald, Craig S, Feron, Lyman J L, Karoutchi, Galith, MacFaul, Philip, Moss, Thomas, Norman, Richard A, Pearson, Stuart E, Tonge, Michael, Davies, Gareth, Walker, Graeme E, Wilson, Zena, Rowlinson, Rachel, Powell, Steve, Sadler, Claire, Richmond, Graham, Ladd, Brendon, Pazolli, Ermira, Mazzola, Anne Marie, D'Cruz, Celina, De Savi, Chris
Published in Cancer research (Chicago, Ill.) (01.06.2016)
Published in Cancer research (Chicago, Ill.) (01.06.2016)
Get full text
Journal Article
Allosteric PI3Kα Inhibition Overcomes On-target Resistance to Orthosteric Inhibitors Mediated by Secondary PIK3CA Mutations
Varkaris, Andreas, Fece de la Cruz, Ferran, Martin, Elizabeth E, Norden, Bryanna L, Chevalier, Nicholas, Kehlmann, Allison M, Leshchiner, Ignaty, Barnes, Haley, Ehnstrom, Sara, Stavridi, Anastasia-Maria, Yuan, Xin, Kim, Janice S, Ellis, Haley, Papatheodoridi, Alkistis, Gunaydin, Hakan, Danysh, Brian P, Parida, Laxmi, Sanidas, Ioannis, Ji, Yongli, Lau, Kayao, Wulf, Gerburg M, Bardia, Aditya, Spring, Laura M, Isakoff, Steven J, Lennerz, Jochen K, Del Vecchio, Kathryn, Pierce, Levi, Pazolli, Ermira, Getz, Gad, Corcoran, Ryan B, Juric, Dejan
Published in Cancer discovery (08.02.2024)
Published in Cancer discovery (08.02.2024)
Get full text
Journal Article
Abstract P5-16-10: RLY-2608: The first allosteric mutant- and isoform-selective inhibitor of PI3Kα, is efficacious as a single agent and drives regressions in combination with standard of care therapies in PIK3CA mutant breast cancer models
Pazolli, Ermira, Kipp, Randy, Boezio, Alessandro, Gunaydin, Hakan, Iskandar, Amanda, Zubrowski, Matthew, Williams, Bret, Shortsleeves, Kelley, Larivee, Alexandre, McLean, Tom, Michelsen, Klaus, Zeng, Hongtao, LaRochelle, Jonathan, Manna, Joe, DiPietro, Lucian, Lescarbeau, Andre, Mader, Mary, Bennet, Bindu, Wilbur, Jeremy, Wang, Qi, Pierce, Levi, Martin, Iain, Watters, James, Fortin, Pascal, Bergstrom, Donald
Published in Cancer research (Chicago, Ill.) (15.02.2022)
Published in Cancer research (Chicago, Ill.) (15.02.2022)
Get full text
Journal Article
Discovery and Clinical Proof-of-Concept of RLY-2608, a First-in-Class Mutant-Selective Allosteric PI3Kα Inhibitor That Decouples Antitumor Activity from Hyperinsulinemia
Varkaris, Andreas, Pazolli, Ermira, Gunaydin, Hakan, Wang, Qi, Pierce, Levi, Boezio, Alessandro A, Bulku, Artemisa, DiPietro, Lucian, Fridrich, Cary, Frost, Adam, Giordanetto, Fabrizio, Hamilton, Erika P, Harris, Katherine, Holliday, Michael, Hunter, Tamieka L, Iskandar, Amanda, Ji, Yongli, Larivée, Alexandre, LaRochelle, Jonathan R, Lescarbeau, André, Llambi, Fabien, Lormil, Brenda, Mader, Mary M, Mar, Brenton G, Martin, Iain, McLean, Thomas H, Michelsen, Klaus, Pechersky, Yakov, Puente-Poushnejad, Erika, Raynor, Kevin, Rogala, Dipali, Samadani, Ramin, Schram, Alison M, Shortsleeves, Kelley, Swaminathan, Sweta, Tajmir, Shahein, Tan, Gege, Tang, Yong, Valverde, Roberto, Wehrenberg, Bryan, Wilbur, Jeremy, Williams, Bret R, Zeng, Hongtao, Zhang, Hanmo, Walters, W Patrick, Wolf, Beni B, Shaw, David E, Bergstrom, Donald A, Watters, James, Fraser, James S, Fortin, Pascal D, Kipp, D Randal
Published in Cancer discovery (08.02.2024)
Published in Cancer discovery (08.02.2024)
Get full text
Journal Article
Abstract P251: Discovery and characterization of RLY-2608: The first allosteric, mutant, and isoform-selective inhibitor of PI3Kα
Pazolli, Ermira, Kipp, Randy, Boezio, Alessandro, Gunaydin, Hakan, Iskandar, Amanda, Zubrowski, Matthew, Williams, Bret, Shortsleeves, Kelley, Larivee, Alexandre, McLean, Tom, Michelsen, Klaus, Zeng, Hongtao, LaRochelle, Jonathan, Manna, Joe, DiPietro, Lucian, Mader, Mary, Bennet, Bindu, Wilbur, Jeremy, Wang, Qi, Pierce, Levi, Martin, Iain, Watters, James, Fortin, Pascal, Bergstrom, Donald
Published in Molecular cancer therapeutics (01.12.2021)
Published in Molecular cancer therapeutics (01.12.2021)
Get full text
Journal Article
c-Myb and C/EBPβ regulate OPN and other senescence-associated secretory phenotype factors
Flanagan, Kevin C, Alspach, Elise, Pazolli, Ermira, Parajuli, Shankar, Ren, Qihao, Arthur, Laura L, Tapia, Roberto, Stewart, Sheila A
Published in Oncotarget (02.01.2018)
Published in Oncotarget (02.01.2018)
Get full text
Journal Article
Senescence: the good the bad and the dysfunctional
Pazolli, Ermira, Stewart, Sheila A
Published in Current opinion in genetics & development (01.02.2008)
Published in Current opinion in genetics & development (01.02.2008)
Get full text
Journal Article
Abstract 281: Sensitivity to splicing modulation of BCL2 family genes reveals cancer therapeutic strategies for splicing modulators
Aird, Daniel, Teng, Teng, Huang, Chia-Ling, Pazolli, Ermira, Banka, Deepti, Cheung-Ong, Kahlin, Eifert, Cheryl, Furman, Craig, Wu, Jeremy, Seiler, Michael, Buonamici, Silvia, Fekkes, Peter, Karr, Craig, Palacino, James, Park, Eunice, Smith, Peter, Yu, Lihua, Mizui, Yoshiharu, Warmuth, Markus, Chicas, Agustin, Corson, Laura, Zhu, Ping
Published in Cancer research (Chicago, Ill.) (01.07.2019)
Published in Cancer research (Chicago, Ill.) (01.07.2019)
Get full text
Journal Article
Abstract GS03-10: Allosteric PI3K-alpha inhibition overcomes on-target resistance to orthosteric inhibitors mediated by secondary PIK3CA mutations
Varkaris, Andreas, Cruz, Ferran Fece de la, Martin, Elizabeth, Nordern, Bryanna, Chevalier, Nicholas, Leshchiner, Ignaty, Stavridi, Anastasia, Kim, Janice, Papatheodoridi, Alkistis, Gunaydin, Hakan, Danysh, Brian, Parida, Laxmi, Sanidas, Ioannis, Ji, Yongli, Lau, Kayao, Wulf, Gerburg, Bardia, Aditya, Spring, Laura, Isakoff, Steven, Lennerz, Jochen, Pierce, Levi, Pazolli, Ermira, Getz, Gad, Corcoran, Ryan, Juric, Dejan
Published in Cancer research (Chicago, Ill.) (02.05.2024)
Published in Cancer research (Chicago, Ill.) (02.05.2024)
Get full text
Journal Article
SPLICING MODULATOR ANTIBODY-DRUG CONJUGATE AND USAGE THEREOF
ANDREW COOK, DOMINIC REYNOLDS, PETER SMITH, XIAO YONGHONG, WU ZHENHUA, PENG SHOUYONG, LIU XIANG, ZHU PING, SUDEEP PRAJAPATI, JAMES PALACINO, NICHOLAS CALANDRA, YU LIHUA, ERMIRA PAZOLLI, NATHAN FISHKIN, THIWANKA SAMARAKOON, MICHAEL SEILER, SILVIA BUONAMICI, SHELBY ELLERY, MEGAN SHEEHAN
Year of Publication 21.02.2024
Get full text
Year of Publication 21.02.2024
Patent
H3B-8800, an Orally Bioavailable Modulator of the SF3b Complex, Shows Efficacy in Spliceosome-Mutant Myeloid Malignancies
Buonamici, Silvia, Yoshimi, Akihide, Thomas, Michael, Seiler, Michael, Chan, Betty, Caleb, Benjamin, Darman, Rachel, Fekkes, Peter, Karr, Craig, Keaney, Gregg F., Klimek, Virginia M., Kunii, Kaiko, Lee, Linda, Lee, Stanley Chun-Wei, Liu, Xiang, Meeske, Carol, Mizui, Yoshiharu, Padron, Eric, Park, Eunice, Pazolli, Ermira, Prajapati, Sudeep, Taylor, Justin, Wang, John, Warmuth, Markus, Yu, Lihua, Zhu, Ping, Abdel-Wahab, Omar, Smith, Peter G
Published in Blood (02.12.2016)
Published in Blood (02.12.2016)
Get full text
Journal Article
Abstract 1185: H3B-8800, a novel orally available SF3b modulator, shows preclinical efficacy across spliceosome mutant cancers
Buonamici, Silvia, Yoshimi, Akihide, Thomas, Michael, Seiler, Michael, Chan, Betty, Caleb, Benjamin, Csibi, Fred, Darman, Rachel, Fekkes, Peter, Karr, Craig, Keaney, Gregg, Kim, Amy, Klimek, Virginia, Kumar, Pavan, Kunii, Kaiko, Lee, Stanley Chun-Wei, Liu, Xiang, MacKenzie, Crystal, Meeske, Carol, Mizui, Yoshiharu, Padron, Eric, Park, Eunice, Pazolli, Ermira, Prajapati, Sudeep, Rioux, Nathalie, Taylor, Justin, Wang, John, Warmuth, Markus, Yao, Huilan, Yu, Lihua, Zhu, Ping, Abdel-Wahab, Omar, Smith, Peter
Published in Cancer research (Chicago, Ill.) (01.07.2017)
Published in Cancer research (Chicago, Ill.) (01.07.2017)
Get full text
Journal Article
Abstract A146: Preclinical models relevant to the treatment of post-menopausal breast cancer
Pazolli, Ermira, Mazzola, Anne Marie, Curwen, Jon, Weir, Hazel, Kiessel, Casey, Grondine, Michael, D'Cruz, Celina, Zinda, Mike
Published in Molecular cancer therapeutics (01.11.2013)
Published in Molecular cancer therapeutics (01.11.2013)
Get full text
Journal Article
Abstract 2941: Targeting MCL1-dependent cancers through RNA splicing modulation
Park, Eun Sun, Aicher, Michelle, Aird, Daniel, Buonamici, Silvia, Chan, Betty, Eifert, Cheryl, Fekkes, Peter, Furman, Craig, Gerard, Baudouin, Karr, Craig, Keaney, Gregg, Kunii, Kaiko, Lee, Linda, Pazolli, Ermira, Prajapati, Sudeep, Satoh, Takashi, Smith, Peter, Wang, John Yuan, Wang, Karen, Warmuth, Markus, Yu, Lihua, Zhu, Ping, Mizui, Yoshiharu, Corson, Laura B.
Published in Cancer research (Chicago, Ill.) (01.08.2015)
Published in Cancer research (Chicago, Ill.) (01.08.2015)
Get full text
Journal Article